US Physical Therapy Files 8-K

Ticker: USPH · Form: 8-K · Filed: Aug 16, 2024 · CIK: 885978

Sentiment: neutral

Topics: sec-filing, regulation-fd, financial-statements

Related Tickers: USPHY

TL;DR

USPHY filed an 8-K, likely containing regulatory disclosures and financial updates.

AI Summary

On August 14, 2024, U.S. Physical Therapy, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt.

Why It Matters

This filing indicates that U.S. Physical Therapy, Inc. is providing updates or disclosures to the SEC, which could contain important information for investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific material events or financial data that would indicate a change in risk.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

What is the exact name of the registrant?

The exact name of the registrant is U.S. PHYSICAL THERAPY, INC.

In which state is U.S. Physical Therapy, Inc. incorporated?

U.S. Physical Therapy, Inc. is incorporated in Nevada.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported is August 14, 2024.

What is the principal executive office address for U.S. Physical Therapy, Inc.?

The principal executive office address is 1300 WEST SAM HOUSTON PARKWAY, SUITE 300, HOUSTON, Texas 77043.

Filing Stats: 565 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-08-16 16:05:18

Filing Documents

01 Regulation FD Disclosure

ITEM 7.01 Regulation FD Disclosure. On August 14, 2024, U.S. Physical Therapy (the "Company") hosted a conference call and webcast to discuss its results for the second quarter and six months ended June 30, 2024. The transcript of the conference call is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The Company updated its investor presentation and is furnished as Exhibit 99.2 to this Current Report on Form 8-K. The presentation covers an overview of the Company and is also available on the Company's website at www.usph.com. The information in this Current Report on Form 8-K, including the exhibits, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01 FINANCIAL STATEMENTS AND EXHIBITS

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS Exhibits Description of Exhibits 99.1 Registrant's August 14, 2024 Conference Call Transcript Discussing Second Quarter and Six Months Ended June 30, 2024 99.2 Investor Presentation for Q2 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. U.S. PHYSICAL THERAPY, INC. Dated: August 16, 2024 By: /s/ CAREY HENDRICKSON Carey Hendrickson Chief Financial Officer (duly authorized officer and principal financial and accounting officer)

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing